Telomere Dysfunction in Peripheral Lymphocytes as a Potential Predisposition Factor for Renal Cancer
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
PURPOSE: Genetic integrity is maintained in part by the architecture of telomeres. We previously developed a laser scanning cytometry based quantitative fluorescence in situ hybridization assay to assess telomere length in peripheral blood lymphocytes. In this study we modified the assay by incorporating 9 control cell lines to normalize telomere length. MATERIALS AND METHODS: We applied this assay to 65 patients with renal cell carcinoma, and 65 age, sex and ethnicity matched controls. For each subject we measured telomere length in CD4+ T cells, CD8+ T cells and overall peripheral blood lymphocytes. RESULTS: For cases vs controls mean normalized telomere length +/- SD was 0.84 +/- 0.15 vs 0.95 +/- 0.18 for CD4+ T cells, 0.80 +/- 0.21 vs 0.95 +/- 0.22 for CD8+ T cells and 0.88 +/- 0.25 vs 0.99 +/- 0.22 for overall peripheral blood lymphocytes (each p <0.05). After adjustment for patient age, sex, ethnicity and smoking status, and using 75% of telomere length in controls as a cutoff point, short telomere length in CD4+ T cells was associated with a significantly increased risk of renal cell carcinoma (OR 3.08, 95% CI 1.14-8.34). Compared to individuals within the highest quartile of telomere length the OR for those within the 3rd, 2nd and 1st quartiles was 1.81 (95% CI 0.54-6.08), 2.15 (95% CI 0.67-6.91) and 5.41 (95% CI 1.78-16.4), respectively (p for trend <0.01). Similar trends were observed in CD8+ T cells and overall peripheral blood lymphocytes. In controls there was no significant difference among the telomere lengths of CD4+ T cells, CD8+ T cells and overall PBLs. CONCLUSIONS: Our data argue against the possibility that telomere length difference between cancer cases and controls may be due to the variations of lymphocyte subpopulation or clonal expansion. Our data strongly support the hypothesis that telomere shortening in peripheral blood lymphocytes is a genetic predisposing factor for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rufer, N., Brümmendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., Schulzer, M., & Lansdorp, P. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.157 · Cited by 709
In situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer
Broberg, K., Björk, J., Paulsson, K., Höglund, M., & Albin, M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi063 · Cited by 255
Cited by
Telomere length and risk of incident cancer and cancer mortality
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010) · JAMA · doi:10.1001/jama.2010.897 · Cited by 484
“Current evidence mainly derives from case-control studies and is inconsistent for various specific types of cancer.(7-15) Few evaluations have been prospective in design and have measured telomere length well in advance of cancer manifestation; all of the studies, to date, were conducted in selected patient groups or…”
ResultThe association of telomere length and cancer: a meta-analysis
Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0005 · Cited by 458
“Bladder, lung, renal (11) Bladder (22) Bladder (12) Breast (28) Breast (14) Breast (13) Breast (37) Breast (38) Breast (37) Breast (25) Breast (30) Breast (29) Breast (25) CRC (33) CRC (20) CRC (25) CRC (25) Endometrial (26) Esophagus (27) Esophagus (32) Gastric (21) Gastric (17) HNC (11) Incident cancer (31) Lung (18…”
BackgroundShortened Telomere Length Is Associated with Increased Risk of Cancer: A Meta-Analysis
Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K. A., Dunning, A. M., Svenson, U., Roos, G., Hosgood, H. D., Shen, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020466 · Cited by 376
“Shao [22] 2007 USA Mixed Renal Cancer 65/65 Retrospective Hospital-based Lymphocytes Q-FISHLSC”
InfluentialContemporary Epidemiology of Renal Cell Cancer
Chow, W.-H., & Devesa, S. S. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e3181867628 · Cited by 281
Shortened telomeres in individuals with abuse in alcohol consumption
Pavanello, S., Hoxha, M., Dioni, L., Bertazzi, P. A., Snenghi, R., Nalesso, A., Ferrara, S. D., Montisci, M., & Baccarelli, A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25999 · Cited by 167
Metadata
- Authors
- Shao, L., Wood, C. G., Zhang, D., Tannir, N. M., Matin, S., Dinney, C. P., & Wu, X.
- Venue
- Journal of Urology
- Published
- 2007-10
- Volume
- 178
- Issue
- 4
- Pages
- 1492-1496
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2031533538
- Cited by
- 85
- References
- 3
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomere Dysfunction in Peripheral Lymphocytes as a Potential Predisposition Factor for Renal Cancer. https://app.cochat.ai/papers/10.1016/j.juro.2007.05.112
- The paper
- Shao, L., Wood, C. G., Zhang, D., Tannir, N. M., Matin, S., Dinney, C. P., & Wu, X. (2007). Telomere Dysfunction in Peripheral Lymphocytes as a Potential Predisposition Factor for Renal Cancer. Journal of Urology. https://doi.org/10.1016/j.juro.2007.05.112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.